Description
Mast Cell Tumours by Douglas Thamm. Mast cell tumors (MCT) are extremely common in small animal practice, and are characterized by a very wide variation in biology and behavior. However, 70% of canine MCT and even more feline MCT can be effectively treated with surgery alone, and a relatively straightforward algorithm can be used to appropriately treat the vast majority of MCT encountered in practice. This lecture will cover the basics of diagnostic tests, staging, and surgical, medical and radiation-based approaches for canine MCT treatment.
Dr. Thamm is also a member of the Developmental Therapeutics Section of the University of Colorado Comprehensive Cancer Center and the Cell and Molecular Biology Graduate Program at Colorado State University. Dr. Thamm received his Bachelors and VMD degrees from the University of Pennsylvania. He completed an Oncology Residency at the University of Wisconsin, and was a researcher there for 5 additional years before joining the faculty at CSU in 2004. He has authored over 115 peer-reviewed publications and 20 book chapters in veterinary and basic cancer research, was Oncology Section Editor for the 2 most recent editions of Kirk’s Current Veterinary Therapy and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology. His clinical and research interests include novel targeted therapies for animal and human cancer and ways to integrate these therapies with existing treatment.